World PI Week is a global campaign dedicated to raising awareness of PI. Explore how we can work together to improve patients’ lives through timely access to quality care.
In the U.S. alone, primary immunodeficiency diseases (PID) affects about 270,000 people.1 Approximately 70,000 (26%) of them receive immunoglobulin (Ig) therapy.2
The Freedom™ Infusion System helps many of these patients receive subcutaneous infusions of Hizentra®, HyQvia®*, Cuvitru®, Cutaquig®, or Xembify® in the comfort of their homes, using either the large volume Freedom60® or smaller volume FreedomEDGE® pumps.
*Outside US only
The Immune Deficiency Foundation’s online Resource Center has an abundance of materials and tools to help patients and family members of those with Primary Immunodeficiencies stay informed.
www.primaryimmune.org/resource-center
Join the immune globulin community with access to IG Living magazine, advocacy groups, expert opinions, and patients with rare diseases.
www.igliving.com
The Jeffrey Modell Foundation directs efforts toward early diagnosis, meaningful treatments, equal access to care, and ultimately, a cure for Primary Immunodeficiency.
www.info4pi.org
Koru’s Patient Support Program is dedicated to supporting your success with at-home subcutaneous infusion therapy.
Download the Freedom Journey flyer
KORU Medical Systems, Inc.
100 Corporate Drive
Mahwah, NJ 07430 USA
Tel: +1-800-624-9600
Fax: +1-845-469-5518